If things go according to plan, the vaccine would be available in the market by the end of this year. IMAGE: Kindly note that this image has been posted for representational purposes only.......
The country's first messenger mRNA vaccine is expected to begin trials on humans in February. IMAGE: A health worker administers a dose of COVID-19 vaccine to a beneficiary during a vaccination......
The country's first indigenous mRNA vaccine candidate developed by Gennova, Pune has received approval from drug regulators to initiate Phase 1/2 human clinical trials, the Department of......
India's first mRNA platform-based vaccine will remain stable at 2-8 degrees Celsius while Pfizer-BioNTech's vaccine needs minus 70 degrees Celsius and Moderna vaccine can remain stable for six......
Gennova has also got permission for phase-2 and 3 clinical trials for its lyophilised mRNA vaccine for injection from the subject expert committee advising the Central Drugs Standards Control......